ENTITY
Roche Holding

Roche Holding (ROG SW)

47
Analysis
Health CareUnited States
Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system. Roche Holding serves customers worldwide.
more
Refresh
bullishZhaoke Ophthalmology Pharmaceutical18 Feb 2021 01:03

Zhaoke Ophthalmology: Bringing Focus to China

Zhaoke Ophthalmology is a pre-revenue pharmaceutical company specializing in ophthalmic drugs for China that has filed to list on the HKEX. Lee's...

Share
bullishJD Health International 26 Nov 2020 21:49
Smartkarma Originals

Asian Healthcare - Coming of Age

This Smartkarma Originals Insight highlights 20 leading unlisted healthcare companies in Asia, mainly in digital healthcare and biopharma, that are...

Share
bullishVolkswagen (Pref)19 Sep 2023 19:39

Liquid Universe of European Ordinary and Preferred Shares: September‘23 Report

Since mid-August, spreads have not followed a clear pattern across the European liquid universe of ordinary and preferred shares (10 have...

bearishNeusoft Xikang Healthcare Technology Co Ltd27 Aug 2023 09:41

China Healthcare Weekly (Aug.25) - Anti Corruption Affects IPO, TIGIT Revives Again? Neusoft Xikang

Corruption crackdown has affected companies’ IPO.Investors need to be aware of potential risk. Roche's TIGIT data bring a glimmer of hope but we...

Share
bearishWuXi XDC Cayman Inc17 Aug 2023 10:31

WuXi XDC Cayman Pre-IPO - The Negatives - Bottlenecks Have Held Margins Back. Receivables Ballooning

WuXi XDC Cayman Inc (1877628D HK) is looking to raise at least US$100m in its upcoming Hong Kong IPO. In this note, we will talk about the not-so...

Logo
Clarence Chu
322 Views
Share
x